# FDA Inspection 638294 - Berger, Daniel  M.D. - November 24, 2009

Source: https://www.keypedia.com/records/fda_inspections/berger-daniel-md/a04a864c-c7da-423e-a6d3-938d525f3d1b
Source feed: FDA_Inspections

> FDA Inspection 638294 for Berger, Daniel  M.D. on November 24, 2009. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 638294
- Company Name: Berger, Daniel  M.D.
- Inspection Date: 2009-11-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 996685 - 2016-11-15](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/45d658e2-2204-4c95-810c-504af4772840)
- [FDA Inspection 902528 - 2014-12-04](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/4ecb0e35-8eb2-41cb-9b0f-cf3c62e35f31)
- [FDA Inspection 583659 - 2009-05-13](https://www.keypedia.com/records/fda_inspections/berger-daniel-md/e3ee9e35-e0a0-4260-9813-270e093fe028)

Company: https://www.keypedia.com/companies/berger-daniel-md/dea74c20-80ec-41ee-a1f1-34cdb0399b2a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c